Abstract
Gram-positive cocci are responsible for many severe infections in community and hospital settings, and these multidrug resistant organisms have increased markedly in the past decade. This trend is particularly evident for methicillin/ oxacillin-resistant Staphylococcus aureus (MRSA). MRSA is any strain of Staphylococcus aureus that has developed resistance to beta-lactam antibiotics, which include the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. S. aureus strains have developed resistance to almost all antibiotics, thereby complicating disease management. Antibiotics are an essential part of modern medicine and that has helped dramatically in curing patients suffering from bacterial infections. However, emerging antimicrobial resistance in bacteria threatens to undermine the management of bacterial infections. A number of factors, which may promote antimicrobial resistance such as availability of antimicrobials without prescription, suboptimal hygiene, immunosuppression due to malnutrition or HIV, aggressive cancer chemotherapy and an increase in organ transplantation have resulted in hospitalized patients with immune compromise at high risk of nosocomial infections. The emergence of antibiotic-resistant mutants among bacteria is seemingly inevitable, that results in the decreased efficacy and withdrawal of the antibiotic from wide-spread usage. The purpose of this review is to discuss the increase in isolates of multidrug resistant S. aureus which has created an urgent need for the development of new anti-staphylococcal agents.
Keywords: Staphylococcus aureus, MRSA, antibiotics, mechanism of resistance
Anti-Infective Agents
Title:Emergence of Methicillin-Resistant Staphylococcus aureus (MRSA) as a Public-Health Threat and Future Directions of Antibiotic Therapy for MRSA Infections
Volume: 10 Issue: 2
Author(s): Harsha Patel, Yogeshkumar Vaghasiya, BRM Vyas and Sumitra Chanda
Affiliation:
Keywords: Staphylococcus aureus, MRSA, antibiotics, mechanism of resistance
Abstract: Gram-positive cocci are responsible for many severe infections in community and hospital settings, and these multidrug resistant organisms have increased markedly in the past decade. This trend is particularly evident for methicillin/ oxacillin-resistant Staphylococcus aureus (MRSA). MRSA is any strain of Staphylococcus aureus that has developed resistance to beta-lactam antibiotics, which include the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. S. aureus strains have developed resistance to almost all antibiotics, thereby complicating disease management. Antibiotics are an essential part of modern medicine and that has helped dramatically in curing patients suffering from bacterial infections. However, emerging antimicrobial resistance in bacteria threatens to undermine the management of bacterial infections. A number of factors, which may promote antimicrobial resistance such as availability of antimicrobials without prescription, suboptimal hygiene, immunosuppression due to malnutrition or HIV, aggressive cancer chemotherapy and an increase in organ transplantation have resulted in hospitalized patients with immune compromise at high risk of nosocomial infections. The emergence of antibiotic-resistant mutants among bacteria is seemingly inevitable, that results in the decreased efficacy and withdrawal of the antibiotic from wide-spread usage. The purpose of this review is to discuss the increase in isolates of multidrug resistant S. aureus which has created an urgent need for the development of new anti-staphylococcal agents.
Export Options
About this article
Cite this article as:
Patel Harsha, Vaghasiya Yogeshkumar, Vyas BRM and Chanda Sumitra, Emergence of Methicillin-Resistant Staphylococcus aureus (MRSA) as a Public-Health Threat and Future Directions of Antibiotic Therapy for MRSA Infections, Anti-Infective Agents 2012; 10 (2) . https://dx.doi.org/10.2174/2211362611208020149
DOI https://dx.doi.org/10.2174/2211362611208020149 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ceftriaxone-Vancomycin Drug Toxicity Reduction by VRP 1020 in Mus musculus Mice
Current Clinical Pharmacology Heart Failure in Acute Ischemic Stroke
Current Cardiology Reviews Current Status of Molecular Imaging in Infections
Current Pharmaceutical Design Cardiovascular Disease in Antiphospholipid Syndrome
Current Vascular Pharmacology The Family of Serratia Type Pore Forming Toxins
Current Protein & Peptide Science Perioperative Management of Patients with Down Syndrome
Current Pediatric Reviews The First Years of Linezolid Experience in Clinical Practice: A Balance and Future Implications
Anti-Infective Agents in Medicinal Chemistry Dendrimers and Dendritic Polymers as Anti-infective Agents: New Antimicrobial Strategies for Therapeutic Drugs
Anti-Infective Agents in Medicinal Chemistry β-Lactams in the New Millennium. Part-II: Cephems, Oxacephems, Penams and Sulbactam
Mini-Reviews in Medicinal Chemistry Allergic Bronchopulmonary Aspergillosis: AllA Radiologist Needs To Know
Current Pediatric Reviews Nanomedical Strategies for Targeting Skin Microbiomes
Current Drug Metabolism Hallmarks in the Therapeutic Approach of Aortic Aneurysms: The Main Contributors
Current Pharmaceutical Design Biofilms and their Role in the Resistance of Pathogenic Candida to Antifungal Agents
Current Drug Targets Autoimmune Fibrotic Adverse Reactions in One-Year Treatment with Cabergoline for Women with Prolactinoma
Endocrine, Metabolic & Immune Disorders - Drug Targets Driving Forces of Mechanisms Regulating Oxacillin-Resistance Phenotypes of MRSA: Truly Oxacillin-Susceptible mecA-Positive Staphylococcus aureus Clinical Isolates also Exist
Current Pharmaceutical Design HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Importance of Oral Health in Pregnancy: A Mini-symposium
Current Women`s Health Reviews Pre-clinical Impact of the Synergistic Mechanism of Daptomycin and Ceftaroline on Patients with Methicillin-resistant Staphylococcus aureus Bacteremia Infections
Current Reviews in Clinical and Experimental Pharmacology Prosthetic Valve Endocarditis: Diagnostic Approach and Treatment Options
Cardiovascular & Hematological Disorders-Drug Targets Scintigraphic Imaging of Inflammatory Processes
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents